2-(3-sulfanylpropyl)pentanedioic acid
|
2-(3-sulfanylpropyl)pentanedioic acid
|
254737-29-6
|
(S)-1,2,3,4-tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methylisoquinolin-7-ol
|
牛心果鹼
|
485-19-8
|
4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]benzoic Acid
|
4-[4-[[2-(4-氯苯基)-5,5-二甲基-1-环己烯]甲基]-1-哌嗪基]苯甲酸
|
1044598-91-5
|
ponatinib
|
泊那替尼
|
943319-70-8
|
3-(2-iMidazo[1,2-b]pyridazin-3-ylethynyl)-4-Methyl-Benzoic acid
|
3-(2-咪唑[1,2-B]吡嗪-3-基乙炔基)-4-甲基苯甲酸
|
1300690-48-5
|
Navitoclax
|
ABT 263
|
923564-51-6
|
BenzaMide, 3-iodo-4-Methyl-N-[4-[(4-Methyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-
|
3-碘-4-甲基-N-[4-[(4-甲基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]苯甲酰胺
|
943320-50-1
|
N-Methylcoclaurine
|
D-甲基乌药碱
|
5096-70-8
|
ETHYL IMIDAZO[1,2-A]PYRAZINE-2-CARBOXYLATE
|
咪唑并[1,2-A]吡嗪-2-甲酸乙酯
|
77112-52-8
|
1417694-51-9
|
|
1417694-51-9
|
3-Ethynylimidazo[1,2-b]pyridazine
|
3-炔基咪唑[1,2-B]哒嗪
|
943320-61-4
|
Bcl-2/Bcl-xl inhibitor 1
|
Bcl-2/Bcl-xl inhibitor 1
|
2180923-05-9
|
DIMBOA
|
丁布
|
15893-52-4
|
1,2,3,4-TETRAHYDRO-8-QUINOLINECARBONITRILE
|
1,2,3,4-四氢-8-喹啉甲腈
|
50741-37-2
|
TORIN2
|
9-(6-氨基-3-吡啶基)-1-[3-(三氟甲基)苯基]苯并[H]-1,6-萘啶-2(1H)-酮
|
1223001-51-1
|
TORIN1
|
1-[4-[4-(1-氧代丙基)-1-哌嗪基]-3-(三氟甲基)苯基]-9-(3-喹啉基)苯并[H]-1,6-萘啶-2(1H)-酮
|
1222998-36-8
|
Ponatinib Hydrochloride
|
泊那替尼盐酸盐
|
1114544-31-8
|
coclaurine
|
衡州乌药碱
|
486-39-5
|
MCC950
|
N-[[(1,2,3,5,6,7-六氢-S-引达省-4-基)氨基]羰基]-4-(1-羟基-1-甲基乙基)-2-呋喃磺酰胺单钠盐
|
256373-96-3
|
ISRIB
|
ISRIB(TRANS-ISOMER) 抑制剂
|
1597403-47-8
|
TIZANIDINE RELATED COMPOUND C (50 MG) (1-ACETYLIMIDAZOLIDINE-2-THIONE)
|
替扎尼定相关物质C
|
5391-52-6
|
|
|
153109-50-3
|
1-Methyl-4-[[4-nitro-2-(trifluoromethyl)phenyl]methyl]-piperazine
|
4-(4-甲基哌嗪-1-亚甲基)-3-三氟甲基-1-硝基苯
|
694499-24-6
|
GZD824
|
GZD824
|
1257628-77-5
|
GZD824
|
GZD824DIMESYLATE
|
1421783-64-3
|
PLX8394
|
PLX8394
|
1393466-87-9
|
methyl 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methylbenzoate
|
BENZOIC ACID, 3-(2-IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-, METHYL ESTER
|
1356385-96-0
|
SPIRO[3.5]NONAN-6-ONE
|
螺[3.5]壬烷-6-酮
|
74064-35-0
|
PHA-543613
|
化合物PHA 543613
|
478149-53-0
|
4-(4-Methyl-piperazin-1-ylmethyl)-3-trifluoromethyl-phenylamine
|
3-三氟甲基-4-[(4-甲基哌嗪-1-基)甲基]苯胺
|
694499-26-8
|
ABC99
|
ABC99
|
2331255-53-7
|